Terms: = Brain cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Prognosis
15 results:
1. [Dynamic trajectory and cell communication of different cell clusters in malignant progression of glioblastoma].
Cai X; Wang R; Wang S; Ren Z; Yu Q; Li D
Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Apr; 56(2):199-206. PubMed ID: 38595234
[TBL] [Abstract] [Full Text] [Related]
2. The evaluation of six genes combined value in glioma diagnosis and prognosis.
Lin P; He L; Tian N; Qi X
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12413-12433. PubMed ID: 37439825
[TBL] [Abstract] [Full Text] [Related]
3. Integrated genomic, transcriptomic, and epigenetic analyses identify a leukotriene synthesis-related M2 macrophage gene signature that predicts prognosis and treatment vulnerability in gliomas.
Ji H; Liu Z; Wang N; Jin J; Zhang J; Dong J; Wang F; Yan X; Gong Q; Zhao H; Sun H; Li Y; Hu S; You C
Front Immunol; 2022; 13():970702. PubMed ID: 36159811
[TBL] [Abstract] [Full Text] [Related]
4. Multifunctional nanotheranostics for near infrared optical imaging-guided treatment of brain tumors.
Zhang L; Liu Y; Huang H; Xie H; Zhang B; Xia W; Guo B
Adv Drug Deliv Rev; 2022 Nov; 190():114536. PubMed ID: 36108792
[TBL] [Abstract] [Full Text] [Related]
5. Identification of a novel circular RNA circZNF652/miR-486-5p/serpine1 signaling cascade that regulates cancer aggressiveness in glioblastoma (GBM).
Liu L; Xiao S; Wang Y; Zhu Z; Cao Y; Yang S; Mai R; Zheng Y
Bioengineered; 2022 Jan; 13(1):1411-1423. PubMed ID: 35258403
[TBL] [Abstract] [Full Text] [Related]
6. Identification of Autophagy-Related Prognostic Signature and Analysis of Immune Cell Infiltration in Low-Grade Gliomas.
Quan Q; Xiong X; Wu S; Yu M
Biomed Res Int; 2021; 2021():7918693. PubMed ID: 34790823
[TBL] [Abstract] [Full Text] [Related]
7. Novel targetable FGFR2 and FGFR3 alterations in glioblastoma associate with aggressive phenotype and distinct gene expression programs.
Georgescu MM; Islam MZ; Li Y; Traylor J; Nanda A
Acta Neuropathol Commun; 2021 Apr; 9(1):69. PubMed ID: 33853673
[TBL] [Abstract] [Full Text] [Related]
8. Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma.
Georgescu MM; Islam MZ; Li Y; Circu ML; Traylor J; Notarianni CM; Kline CN; Burns DK
Acta Neuropathol Commun; 2020 Jul; 8(1):111. PubMed ID: 32680567
[TBL] [Abstract] [Full Text] [Related]
9. NAMPT, GRN, and serpine1 signature as predictor of disease progression and survival in gliomas.
Vachher M; Arora K; Burman A; Kumar B
J Cell Biochem; 2020 Apr; 121(4):3010-3023. PubMed ID: 31710121
[TBL] [Abstract] [Full Text] [Related]
10. Prenatal diagnosis of pericallosal lipoma: Systematic review.
Joigneau Prieto L; Ruiz Y; Pérez R; De León Luis J
Eur J Paediatr Neurol; 2019 Nov; 23(6):764-782. PubMed ID: 31587959
[TBL] [Abstract] [Full Text] [Related]
11. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
[TBL] [Abstract] [Full Text] [Related]
12. Immunohistochemical characterization of brain-invasive meningiomas.
Backer-Grøndahl T; Moen BH; Arnli MB; Torseth K; Torp SH
Int J Clin Exp Pathol; 2014; 7(10):7206-19. PubMed ID: 25400818
[TBL] [Abstract] [Full Text] [Related]
13. uPA/pai-1 expression and uPA promoter methylation in meningiomas.
Kandenwein JA; Park-Simon TW; Schramm J; Simon M
J Neurooncol; 2011 Jul; 103(3):533-9. PubMed ID: 20862517
[TBL] [Abstract] [Full Text] [Related]
14. [Tumor-associated prognostic factors of the plasminogen activator family: determination and clinical value of u-PA, t-PA, pai-1, and pai-2].
Mengele K; Harbeck N; Reuning U; Magdolen V; Schmitt M
Hamostaseologie; 2005 Aug; 25(3):301-10. PubMed ID: 16113755
[TBL] [Abstract] [Full Text] [Related]
15. The fibrinolytic system in neoplasia.
Bell WR
Semin Thromb Hemost; 1996; 22(6):459-78. PubMed ID: 9122711
[TBL] [Abstract] [Full Text] [Related]
